Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Late-stage round brings in $27mm for LensAR

Executive Summary

LensAR Inc. raised $27mm through a late-stage financing, believed to be its Series F round. Returning investors Aisling Capital, Florida Growth, and Florida Opportunity Funds participated. LensAR will use the new money to continue selling its refractive lasers for cataract surgery in countries throughout North America, Europe, Asia, and Latin America.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Laser
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies